FDA.reportPublic FDA data

{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack

RxCUI
2703053
RxNorm name
{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack
Display name
{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack
Full name
{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761279Omvohmirikizumab-mrkz351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
472cbe04-263e-433d-9a0f-58c1b50b715a{1 (1 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) / 1 (2 ML mirikizumab-mrkz 100 MG/ML Prefilled Syringe) } PackGPCK18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715amirikizumab-mrkz Prefilled Syringe 300 MG Dose Carton - Crohn's DiseaseSY18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104
472cbe04-263e-433d-9a0f-58c1b50b715amirikizumab-mrkz Prefilled Syringe 300 MG Dose Carton - Crohn's DiseasePSN18These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104